344 related articles for article (PubMed ID: 30260171)
1. Immunity to hepatitis A virus among working professionals in Poland - Results of a 3-year serological survey 2013-2015.
Juszczyk G; Czerw AI; Walewska-Zielecka B; Mikos M; Banaś T; Deptała A; Ślusarczyk J
Ann Agric Environ Med; 2018 Sep; 25(3):572-575. PubMed ID: 30260171
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors.
Bura M; Bura A; Adamek A; Michalak M; Marszałek A; Hryckiewicz K; Mozer-Lisewska I
Ann Agric Environ Med; 2012; 19(4):738-41. PubMed ID: 23311799
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria.
Afegbua SL; Bugaje MA; Ahmad AA
Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):627-30. PubMed ID: 23959003
[TBL] [Abstract][Full Text] [Related]
4. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
5. Declining hepatitis A antibody seroprevalence in the Korean military personnel.
Lee CS; Kwon KS; Koh DH; Youm JH; Gwack J; Lee JH
Jpn J Infect Dis; 2010 May; 63(3):192-4. PubMed ID: 20495272
[TBL] [Abstract][Full Text] [Related]
6. The frequency of occurrence anti-HAV antibodies to health employees – own observations.
Moppert J; Zieniewicz-Cieślik K; Tyczyno M; Sobolewska-Pilarczyk M; Pawłowska M
Przegl Epidemiol; 2018; 72(4):453-457. PubMed ID: 30809998
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
Özden HT
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis A immunity in refugees in Germany during the current exodus].
Jablonka A; Solbach P; Happle C; Hampel A; Schmidt RE; Behrens GMN
Med Klin Intensivmed Notfmed; 2017 May; 112(4):347-351. PubMed ID: 27457821
[TBL] [Abstract][Full Text] [Related]
9. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.
Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH
Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182
[TBL] [Abstract][Full Text] [Related]
10. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
[TBL] [Abstract][Full Text] [Related]
11. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
[TBL] [Abstract][Full Text] [Related]
12. Occupational risk of hepatitis A infection among health care providers in northeastern Poland.
Grzeszczuk A; Sokolewicz-Bobrowska E; Chlabicz S
Med Sci Monit; 2003 Jul; 9(7):PH11-4. PubMed ID: 12883461
[TBL] [Abstract][Full Text] [Related]
13. Status of adult immunity to hepatitis A virus in healthcare workers from a tertiary care hospital in north India.
Chauhan S; Agarwal J; Jain A; Sawlani KK; Gupta P; Goel A; Verma N; Himanshu D
Indian J Med Res; 2019 Nov; 150(5):508-511. PubMed ID: 31939396
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of anti-HEV IgG in 182 Polish patients.
Bura M; Michalak M; Chojnicki M; Czajka A; Kowala-Piaskowska A; Mozer-Lisewska I
Postepy Hig Med Dosw (Online); 2015 Mar; 69():320-6. PubMed ID: 25748623
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A seroprevalence in Erzurum, Turkey.
Yilmaz A
Ann Agric Environ Med; 2020 Sep; 27(3):481-484. PubMed ID: 32955233
[TBL] [Abstract][Full Text] [Related]
17. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
18. Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
Bohm K; Filomena A; Schneiderhan-Marra N; Krause G; Sievers C
Vaccine; 2017 Oct; 35(43):5883-5889. PubMed ID: 28919226
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.
Traoré KA; Rouamba H; Nébié Y; Sanou M; Traoré AS; Barro N; Roques P
PLoS One; 2012; 7(10):e48125. PubMed ID: 23110187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
